A Sensitive Denaturing Gradient-Gel Electrophoresis Assay Reveals a High Frequency of Heteroplasmy in Hypervariable Region 1 of the Human mtDNA Control Region**Disclaimer: The opinions and assertions expressed herein are solely those of the authors and are not to be construed as official or the views of the United States Department of Defense, the United States Department of the Army, or the United States Department of Commerce. This paper is a contribution of the United States National Institute of Standards and Technology (NIST) and the United States Department of Defense and is not subject to copyright. Certain commercial equipment, instruments, or companies are identified in this paper to specify the experimental procedure. Such identification does not imply recommendation or endorsement by the government, nor does it imply that the materials or equipment identified are the best available for this purpose.  by Tully, Lois A. et al.
Am. J. Hum. Genet. 67:432–443, 2000
432
A Sensitive Denaturing Gradient-Gel Electrophoresis Assay Reveals
a High Frequency of Heteroplasmy in Hypervariable Region 1 of the
Human mtDNA Control Region
Lois A. Tully,1,† Thomas J. Parsons,2 Robert J. Steighner,2,‡ Mitchell M. Holland,2
Michael A. Marino,3,§ and Valerie L. Prenger1,k
1University of Maryland, School of Medicine, Division of Human Genetics, Baltimore; and 2Armed Forces DNA Identification Laboratory and
3Center for Medical and Molecular Genetics, Armed Forces Institute of Pathology, Rockville, MD
A population study of heteroplasmy in the hypervariable region 1 (HV1) portion of the human mtDNA control
region was performed. Blood samples from 253 randomly chosen individuals were examined using a sensitive
denaturing gradient-gel electrophoresis (DGGE) system. This method is capable of detecting heteroplasmic pro-
portions as low as 1% and virtually all heteroplasmy where the minor component is 5%. Heteroplasmy was
observed in 35 individuals (13.8%; 95% confidence interval [CI] 9.6–18.0). Of these individuals, 33 were hetero-
plasmic at one nucleotide position, whereas 2 were heteroplasmic at two different positions (a condition known
as “triplasmy”). Although heteroplasmy occurred at a total of 16 different positions throughout HV1, it was most
frequently observed at positions 16093 ( ) and 16129 ( ). In addition, the majority of heteroplasmicn = 13 n = 6
variants occurred at low proportions and could not be detected by direct sequencing of PCR products. This study
indicates that low-level heteroplasmy in HV1 is relatively common and that it occurs at a broad spectrum of sites.
Our results corroborate those of other recent reports indicating that heteroplasmy in the control region is more
common than was previously believed—a finding that is of potential importance to evolutionary studies and forensic
applications that are based on mtDNA variation.
Introduction
The control region (CR) of human mtDNA, which is
the only significant noncoding portion of the mtDNA
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genome (Clayton 1992), contains two generally recog-
nized hypervariable regions—hypervariable region 1
(HV1) and hypervariable region 2 (HV2) (Greenberg et
al. 1983; Horai andHayasaka 1990). Sequence variation
in HV1 (length ∼350 bp) within human populations has
been intensively studied, making it the single most im-
portant genetic locus for our understanding of human
evolution and population genetics history (e.g., Vigilant
et al. 1989, 1991; Richards et al. 1996). In addition, the
level of polymorphism in HV1 is high enough to permit
its use as an important tool in human identity testing
(reviewed in Holland and Parsons 1999). This high level
of polymorphism is thought to reflect an extremely high
and variable rate of mutation in the CR (Parsons et al.
1997; Jazin et al. 1998; Parsons and Holland 1998; Ex-
coffier and Yang 1999; Meyer et al. 1999). Numerous
studies have resulted in the determination of thousands
of individual HV1 sequences (Handt et al. 1998), spec-
ifying, within an individual, a single identifiable se-
quence type that very often can be distinguished from
that of individuals from other mtDNA lineages. The
presence of many hundreds of copies of mtDNA per cell,
together with a high mutation rate, creates the potential
for widespread heteroplasmy—that is, the presence of
multiple sequence types within a cell, a tissue, or an
individual. However, the observation of heteroplasmy in
routine sequencing studies is the exception rather than
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the rule. This is thought to be due to a bottleneck in the
transmission of a woman’s mtDNA population to her
offspring that greatly restricts the amount of mtDNA
variation that is passed between generations (Hauswirth
and Laipis 1982; Olivo et al. 1983; Koehler et al. 1991;
Jenuth et al. 1996).
Heteroplasmy in human mtDNA was investigated in
early cloning and sequencing studies done in the 1980s,
with little sequence heterogeneity observed among tis-
sues from normal individuals (Monnat and Loeb 1985;
Monnat and Reay 1986; Bodenteich 1991). Hetero-
plasmy has been widely reported in association with
mitochondrial disorders, where affected individuals har-
bor both mutant and wild-type mtDNA alleles (Wallace
1995); however, the pathogenic nature of these muta-
tions ensures their detection even if they are rare. For
a long time, on the basis of results of population se-
quencing studies, heteroplasmy in the CR was not con-
sidered to be a significant factor in CR sequence vari-
ation (Stoneking 1996). The first report of heteroplasmy
in the CR was in the forensic identity case of Russian
Tsar Nicholas II (Gill et al. 1994; Ivanov et al. 1996).
Subsequently, there have been a number of reports of
CR point-mutation heteroplasmy (Comas et al. 1995;
Bendall et al. 1996; Howell et al. 1996; Jazin et al. 1996;
Sullivan et al. 1996; Bendall et al. 1997; Parsons et al.
1997; Wilson et al. 1997). In addition, it is well doc-
umented that length heteroplasmy is commonly asso-
ciated with polycytosine stretches within both HV1
(Bendall and Sykes 1995; Levin et al. 1996) and HV2
(Marchington et al. 1997; Parsons et al. 1997), appar-
ently occurring quite readily in sequences that have a
run of 8 cytosines.
The frequency of CR point-mutation heteroplasmy is
a question of importance, since it has a central rela-
tionship to the intrinsic rate of base misincorporation
in mtDNA, the size of the intergenerational bottleneck,
and the rate of sequence substitutions within lineages.
The frequency of heteroplasmy is also of practical in-
terest in forensic identity testing (Holland and Parsons
1999), where mtDNA analysis serves as a valuable and
increasingly used tool for identification of old or de-
graded biological evidentiary samples. Although it is
now clear that CR heteroplasmy occurs at an apprecia-
ble frequency, there has been no reliable quantitative
estimate of the population incidence. (However, given
the untold billions of mtDNAs in an individual, we are
all certainly heteroplasmic at some minuscule level.) Di-
rect sequence data have not provided a very useful es-
timate because of the difficulties in distinguishing het-
eroplasmy from various types of sequence background
signal, although recent advances in automated fluores-
cent sequencing chemistry have reduced this problem.
However, in some instances, sequence context–depen-
dent signal-intensity artifacts (Parker et al. 1995, 1996)
can also complicate the characterization of hetero-
plasmy when fluorescent terminator-sequencing chem-
istry is used (see the Results section).
We have implemented a denaturing gradient-gel elec-
trophoresis (DGGE) assay, to perform a population sur-
vey of heteroplasmy in the HV1 portion of the mtDNA
CR. DGGE has been successfully used to identify mu-
tant sequences in nuclear genes (Traystman et al. 1990;
Laubscher et al. 1994) as well as heteroplasmy in the
mitochondrial genome (Yoon et al. 1991; Lombes et al.
1992; Hanekamp et al. 1996; Jazin et al. 1996; Mi-
chikawa et al. 1997; Danan et al. 1999; Michikawa et
al. 1999). In the present study, we report both the fre-
quency of HV1 heteroplasmy in the population, on the
basis of a survey of blood samples from 253 individuals,
and estimates of the heteroplasmic ratios present in
those individuals determined to be heteroplasmic.
Material and Methods
Blood samples, either whole blood or blood spotted onto
filter paper and air-dried, were collected from 253 ran-
domly chosen individuals, none of whom were known
or suspected to be maternally related. All participants
provided appropriate informed consent. Genomic DNA
was isolated using either the Puregene DNA Isolation
Kit (for whole blood; Gentra Systems), according to the
manufacturer’s protocol, or Chelex 100 chelating resin
(for blood spots; Biorad) (Walsh et al. 1991; Holland et
al. 1993).
HV1 was analyzed as two overlapping fragments,
by use of PCR primer pairs F15989 (5′-CCC AAA
GCT AAG ATT CTA AT-3′)/R16258GC (5′-GC TGG
CTT TGG AGT TGC AGT TG-3′) and F16144GC
(5′-GC TGA CCA CCT GTA GTA CAT AA-3′)/
R16410 (5′-GAG GAT GGT GGT CAA GGG AC-3′)
(numbering system of Anderson et al. [1981]). These
primer pairs were designed on the basis of the melt
profiles generated by MacMelt Software (DNA Melt
Profile Macintosh Software for the D Gene System,
version 1.0) for the HV1 region (Steighner et al.
1999). The DNA from individuals with a CrT tran-
sition at position 16189 was reanalyzed using primer
set F15989GC (5′-GC CCC AAA GCT AAG ATT
CTA AT-3′)/R16175 (5′-TGG ATT GGG TTT TTA
TGT A-3′). A GC-clamp (5′-CGC CCG CCG CGC
CCC GCG CCC GTC CCG CCG CCC CCG CCC
G-3′), which was added to the 5′ end of one primer
in each pair (GC), made the resulting PCR products
suitable for DGGE analysis (Myers et al. 1985; Shef-
field et al. 1989; Abrams et al. 1990). PCR amplifi-
cation was performed by combining 10–50 ng DNA
template with 1 # Pfu reaction buffer (20 mM Tris-
HCl pH 8.8, 2 mM MgSO4, 10 mM KCl, 10 mM
(NH4)2SO4, 0.1% Triton X-100, 0.1 mg nuclease-free
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Figure 1 DGGE gel from sensitivity experiments performed to
determine the detection limit of the DGGE system. DNA from an
individual with the standard reference sequence was combined with
DNA from an individual with a TrC polymorphism at position16126,
prior to PCR and testing by DGGE. The concentration of the minority
species could thus be intentionally varied to include 50% (lane 2),
10% (lane 3), 5% (lane 4), 2% (lane 5), 1.3% (lane 6), and 1% (lane
7). Lanes 1 and 8 represent single PCR products from the reference
sequence and the 16126C polymorphism, respectively. Although the
homoduplex band representing the reference sequence was not visible
at a level 10%, the heteroduplexes were clearly seen at levels as low
as 1%. (Reprinted with permission from the American Society for
Testing and Materials.)
BSA per ml), 200 mM each dNTP (Boehringer Mann-
heim), 0.2 mM each primer (Synthetic Genetics), 2 mg
BSA (Sigma Chemical), 2.5 U Pfu polymerase, and
sufficient sterile distilled water (Gibco BRL Life Tech-
nologies) to bring the final volume to 50 ml. (The
accepted SI unit of concentration, mol/L, has been
represented by the symbol “M,” in order to conform
to the conventions of this journal.) PCR cycling con-
sisted of initial denaturation at 95C for 30 s, fol-
lowed by 35 cycles consisting of denaturation at 95C
for 30 s, primer annealing at 50C (F15989/
R16258GC) or 60C (F16144GC/R16410) for 30 s,
and extension at 72C for 30 s. Prior to DGGE anal-
ysis, the PCR products were heated to 95C to de-
nature the DNA and then were slowly cooled to room
temperature to allow for reannealing of the DNA
strands. This heating-and-cooling process resulted in
the formation of a single homoduplex fragment in
homoplasmic individuals and a series of homoduplex
and heteroduplex fragments in heteroplasmic indi-
viduals.
DGGE was performed using a 6.5% polyacrylamide
gel (37.5:1 acrylamide/bisacrylamide [Biorad]) with a
40%–50% chemical (i.e., urea/formamide) denaturing
gradient for 15 h at 100 volts and 60C. The gel was
then stained with 1 # SYBR Green (Molecular Probes)
for 20min andwas visualized using an ultraviolet-wave-
length transilluminator. DGGE separation of homo-
duplex and heteroduplex fragments, followed by elu-
tion, reamplification, and sequencing of the DNA from
DGGE bands, allowed for identification of the hetero-
plasmic positions. The public domain Image program
(developed at the United States National Institutes of
Health) was used to estimate the relative heteroplasmic
proportions (Steighner et al. 1999). Confidence limits
were calculated for the observed population frequency
of heteroplasmy, by use of a standard equation for true
proportions (Colton 1974).
Sequencing analyses were performed using the ABI
PRISM Dye Terminator Cycle Sequencing Kit Taq FS
and the ABI 310 Capillary Electrophoresis Analyzer (PE
Biosystems). Heteroplasmy suspected at position 16189
was evaluated by ligation of the reamplified heterodu-
plex fragment into the pCR-Script Amp SK cloning
vector (Stratagene), followed by transformation into
Epicurian Coli XLJ-Blue supercompetent cells, accord-
ing to the manufacturer’s protocol. After plasmid pu-
rification (Wizard Plus Minipreps DNA Purification
System [Promega]), 10 of the clones were sequenced.
Results
The use of DGGE for mutation or heteroplasmy detec-
tion in HV1 was characterized in a previous study
(Steighner et al. 1999), which demonstrated that this
strategy reliably resolved single-base-pair differences at
140 sites spread evenly throughout HV1. In the present
study, the detection limit of the DGGE assay was in-
vestigated at four positions—16126, 16220, 16298, and
16343—by means of a series of dilution-mixing exper-
iments down to a minority variant proportion of 1:100
(fig. 1). At positions 16126 and 16298, detection of the
minor variant was reliable at the 1% level, whereas, at
16343, the lowest detection was at the 1.3% level (1:
75). Position 16220 was reliably detected at the 5% level
but not below that level. In the course of our population
survey, heteroplasmy was quantified at levels !5% at six
additional scattered sites, three of which were at or be-
low the 1% level. We therefore consider the sensitivity
of the assay for heteroplasmy detection at any site within
HV1 to be 5% or better. Quantitation of heteroplasmic
ratios was performed by densitometric comparison of
heteroduplex and homoduplex band intensity on poly-
acrylamide-gel images. The results of experiments with
mixtures of known quantities showed that this provided
a reasonable approximation of the mixture ratios, with
some tendency toward overestimation of the minority
component as a result of saturation of brighter bands
(fig. 2).
We performed the DGGE heteroplasmy assay on
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Figure 2 Least-squares line fit for known and calculated het-
eroplasmic proportions. A series of simulated heteroplasmic samples
with various proportions of the minor species were analyzed byDGGE.
The known heteroplasmic proportions were plotted against the cal-
culated proportions after densitometric analysis of DGGE gel pho-
tographs (coefficient of correlation .9026).
Table 1
Frequency of HV1 mtDNA Heteroplasmy, as Determined by
DGGE, in a Study Population of 253 Individuals from
Four Ethnic Groups
NO. INDIVIDUALS
ETHNIC GROUP Tested Heteroplasmic FREQUENCY (95% CI)
White 205 30 14.6% (9.8–19.4)
African American 26 3 11.5% (0–23.8)
Hispanic 12 1 8.3% (0–23.9)
Asian 10 1 10.0% (0–28.6)
blood samples from a study population of 253 ran-
domly selected individuals with the following ethnic dis-
tribution: 205 whites, 26 African Americans, 12 His-
panic Americans, and 10 Asians. Samples that appeared
to be heteroplasmic were analyzed a second time, be-
ginning with new DNA extracts, to confirm that het-
eroplasmy was present. Overall, point heteroplasmy
was reproducibly detected in 35/253 individuals in the
study population, resulting in an overall incidence of
13.8% (95% CI 9.6–18.0). In two individuals, two sets
of heteroduplex bands were observed, indicating the
presence of heteroplasmy at two different positions—a
condition known as “triplasmy.” Although the majority
of individuals in the study population were white, het-
eroplasmy was detected in all four racial groups studied,
with no statistically significant differences in the fre-
quencies observed (table 1). Length heteroplasmy as-
sociated with the HV1 polycytosine stretch produced a
complex DGGE pattern and was detected in 30 addi-
tional individuals. This C-stretch length heteroplasmy
generally results from a TrC transition at position
16189 that produces an uninterrupted string of 10 C’s
that is copied with low fidelity during mtDNA repli-
cation (Bendall and Sykes 1995). This was the case in
each of the 30 examined individuals with C-stretch
length heteroplasmy.
The position at which heteroplasmy occurred in a
sample was determined by excising both homoduplex
bands from the DGGE gel and by eluting, reampli-
fying, and sequencing the DNA (fig. 3). When the
proportion of the minor heteroplasmic species was
too low to produce a visible homoduplex band, the
single major homoduplex band (resulting from the
predominant heteroplasmic species) and one or both
heteroduplexes were excised from the DGGE gel and
were eluted, reamplified, and sequenced. Since ream-
plification of either heteroduplex results in a PCR
product containing approximately equal proportions
of both heteroplasmic variants, comparison of the
DNA sequences from the homoduplex and hetero-
duplex bands permitted identification of the hetero-
plasmic site (fig. 4). In some instances, there were
pronounced differences in the intensity of fluorescent
sequence signal for different variants at the position
of interest, on the basis of sequence-specific-strength
artifacts. This made it difficult to identify the hetero-
plasmic position by sequencing of the excised het-
eroduplex band (fig. 5). In those cases, the excised
heteroduplex band was reamplified to produce equal
proportions of the two sequence types, and subse-
quent DGGE gave two strong homoduplex bands.
Comparison of sequences from the two homodu-
plexes then confirmed the heteroplasmic position (fig.
6).
Among the 35 heteroplasmic individuals, hetero-
plasmy was found at 16 different positions and at a
wide range of heteroplasmic ratios (table 2). Six posi-
tions showed heteroplasmy in more than one individual.
There were two observations of heteroplasmy at posi-
tions 16104, 16192, 16362, and 16390. Of note were
two positions that showed an extreme propensity for
heteroplasmy: position 16129 (A/G) was heteroplasmic
in six individuals, and position 16093 (C/T) was het-
eroplasmic in 13 individuals. In one individual, C/T
heteroplasmy was observed at position 16189; this was
also associated with length heteroplasmy in the HV1 C-
stretch within the population of molecules that had C
at position 16189.
In 16/37 instances of heteroplasmy, the majority spe-
cies within the individual corresponded to the variant
that is predominant in the population (table 2). In all
but 2/13 instances of heteroplasmy at position 16093,
T was the minority species, despite the fact that ∼94%
of individuals worldwide manifest a T at that position
(Armed Forces DNA Identification Laboratory data-
base). The relative proportion of the minority species
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Figure 3 mtDNA heteroplasmy at position 16093. The original
PCR product (top) appears to be heteroplasmic (C/T) at position
16093. The sequence data from both homoduplexes (middle and bot-
tom) confirm the heteroplasmic position and sequence.
Figure 4 Homoduplex and heteroduplex DNA sequences. Se-
quence electropherograms of reamplified homoduplex (top) and het-
eroduplex (bottom) DNA from a simulated heteroplasmic sample (pre-
pared by combining two homoplasmic samples differing at a single
position) are shown. Comparison of the sequence data allows for iden-
tification of the heteroplasmic position.
was often low: in 29/36 heteroplasmies, it was !20%
of the mtDNA population, and, in 20 heteroplasmies,
it was !10% (the minority relative proportion was not
determined for the sample with 16189 C/T hetero-
plasmy).
In addition to determination of the position of het-
eroplasmy by means of sequence analysis of bands ex-
cised from DGGE gels, PCR products displaying het-
eroplasmy were directly sequenced on both strands by
automated sequencing using dye-labeled terminators. In
only three instances did we believe that the hetero-
plasmic position was clearly evident by means of direct
sequencing and that it would have been flagged as a
likely instance of heteroplasmy (table 2). This is due to
the low levels of minor heteroplasmic variants in many
cases, but it was also true for some heteroplasmic
mixtures of more-equal proportions. As noted above,
at a number of nucleotide positions, it was readily ap-
parent that the sequence signal from one variant was
intrinsically stronger than that of the other variant, re-
sulting in relative peak heights that did not reflect the
actual proportions of the variants.
Discussion
In this study, a DGGE assay was used to analyze the
heteroplasmic variation in a large population sample of
the mtDNA HV1 region and to characterize the spec-
trum of sites where heteroplasmy most frequently oc-
curs. Of significance, this assay has provided what we
believe to be essentially complete detection of all het-
eroplasmic variants that occur at a level 5% (and, for
most positions, at a level !5%). The results indicate that
heteroplasmy within this detection window is quite com-
mon, occurring in ∼14% of the population and at a
broad spectrum of sites. The incidence found in the pre-
sent study is considerably higher than that reported in
previous studies of HV1 heteroplasmy that used se-
quencing (Bendall et al. 1996) and SSCP analysis (Gocke
et al. 1998), which reported frequencies of 1.48% and
2.53%, respectively.
One area in which heteroplasmy detection may not
have been complete in the present study was proximal
to the HV1 C-stretch region in individuals who carried
a C at position 16189. These 30 individuals displayed
pronounced length heteroplasmy in the C-stretch that
creates a complex DGGE pattern that would have ob-
scured sequence heteroplasmy in this region. To get
around this to the extent possible, for these samples we
used an alternate DGGE primer set—F15989GC/
R16175—that would detect additional sequence het-
eroplasmy, although not beyond position 16155. The
DGGE primer set used for the second half of HV1
(F16144GC/R16410) also would likely fail to detect
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Figure 5 Potential heteroplasmy at position 16192. The se-
quence electropherograms of reamplified homoduplex (top) and het-
eroduplex (bottom) DNA are shown. A very low level of a second
sequence (C) is seen at position 16192 in the heteroduplex. However,
this is insufficient for identification of heteroplasmy.
Figure 6 Sequence electropherograms after analysis of hetero-
duplex DNA by second-round DGGE. The sequences of the lower
band (top) and upper band (bottom) confirmed 16192 as the hetero-
plasmic position.
heteroplasmy close to position 16189, because of the
proximity of the GC-clamped primer to this area. It
should be noted that no sequence heteroplasmy was
detected in any of the 30 individuals with C-stretch–
induced length heteroplasmy. We cannot unequivocally
establish whether this was the result of the reduced abil-
ity to detect heteroplasmy in this restricted region in
individuals with the 16189C polymorphism or whether
these individuals were, in essence, homoplasmic. How-
ell and Bogolin Smejkal (2000) have reported hyper-
mutation of T at position 16192 when there is also a
C polymorphism at position 16189. The two instances
of 16192 heteroplasmy that we observed did have T as
the majority variant, but they were not linked to a
16189C polymorphism. However, the reduced ability
of our DGGE assay to detect heteroplasmy at position
16192 in those individuals with 16189C and resultant
length heteroplasmy may be why we did not observe
the effect reported by Howell and Bogolin Smejkal
(2000).
Our sequencing results underscore the predominant
reason why heteroplasmy in the CR had been unde-
tected for so long and why we have lacked a good es-
timate for its frequency in the population. Direct se-
quencing can provide a poor means for detection of
heteroplasmy, unless extensive confirmatory experi-
ments are performed, and most population studies have
not been conducted with heteroplasmy detection in
mind. This is true not only because low levels of het-
eroplasmy are difficult to distinguish from background
but also because problems can be encountered with ter-
minator-labeled sequencing chemistry, as a result of se-
quence-dependent signal intensity (Parker et al. 1995,
1996). This phenomenon was quite pronounced at po-
sition 16093 (with C having a substantially stronger
inherent signal than T) and is probably responsible for
the failure to convincingly detect heteroplasmy from
direct sequence data at other positions, even when the
proportion of the minor variant was shown by DGGE
to be 20%–25% (e.g., positions 16309, 16301, and
16234).
In considering the results of this study, one should
bear in mind that we are assaying PCR-amplified frag-
ments, as opposed to cellular mtDNA itself. That said,
it is difficult to envision experimental artifacts that
could give rise to these results without the presence of
heteroplasmy in the endogenous mtDNA population.
Point mutations generated from misincorporation dur-
ing the PCR process are expected to be greatly reduced
by the use of a high-fidelity polymerase (Pfu) (Kunkel
and Loeb 1981), and they can be ruled out by the re-
producibility of our results. Contamination of the blood
samples themselves could produce reproducible results,
but we reject this as a general explanation, since mix-
tures were seen only at one or two positions (the latter
in only two samples). Randomly selected white individ-
uals differ from one another at an average of four sites
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Table 2
HV1 Heteroplasmy Data from a Population Survey of 253 Unrelated Individuals
POSITION
(TYPE)a
NO. OF
OBSERVATIONS
REFERENCE
SEQUENCEa
ESTIMATED PROPORTION OF
MINORITY SPECIES IN
HETEROPLASMIC INDIVIDUALS b
RELATIVE RATE OF EVOLUTIONARY
SUBSTITUTIONS PER SITE,
AS ESTIMATED BY
POPULATION
FREQUENCY OF
MINORITY
VARIANTc
Hasegawa
et al.
(1993)
Excoffier
and Yang
(1999)
Meyer et al.
(1999)
16093 (C/T) 13 T .48C, .41T, .26T, .19T, .16T, .13T, .09T,
.08T, .07T, .05T*, .05T, .04T, .03C
8 4.4 3.0 .06
16129 (A/G) 6 G .11A, .09G, .07A, .05A, (BQT)A, (BQT)A 15 4.4 4.8 .12
16104 (C/T) 2 C .10C, .06C 0 .6 .5 .003
16192 (C/T) 2 C .06C, .03C 4 4.4 3.6 .04
16362 (C/T) 2 T .05C, .03C† 13 4.4 4.7 .17
16390 (A/G) 2 G .06A†, .04A 9 … … …
16124 (C/T) 1 T .10C* 4 1.1 .8 .03
16172 (C/T) 1 T .12T 8 4.4 3.8 .07
16185 (C/T) 1 C .23C 3 1.0 .6 .01
16189 (C/T) 1 T (ND)C 15 4.4 4.8 .24
16234 (C/T) 1 C .22T 4 2.2 .8 .01
16256 (C/T) 1 C .16T 5 2.6 2.3 .04
16293 (A/G) 1 A .16A 8 4.4 3.9 .04
16295 (C/T) 1 C (BQT)C 2 .8 .7 .02
16301 (C/T) 1 C .27T 2 1.2 .3 .004
16309 (A/G) 1 A .25A 3 4.3 4.0 .05
a Positions where heteroplasmy was observed. Numbering and sequence are according to Anderson et al. (1981).
b Underlined type denotes heteroplasmy that was distinguishable by direct sequencing; BQT, below quantitation threshold;ND, not determined.
Listings sharing superscripted symbols (asterisk [*] and dagger [†]) indicate that these heteroplasmies were present in the same individual.
c In a forensic database (Armed Forces DNA Identification Laboratory database) of 2263 HV1 sequences with racial proportions similar to
those represented in this study (position 16390 not included in database).
in the HV1 region (Stoneking 1994), and this value is
larger for some of the other racial groups involved. This
same reasoning would eliminate low levels of paternally
inherited mtDNA as a plausible cause of the results.
In principle, another possible cause of the apparent
mixtures we observed with DGGE is the detection of
nuclear pseudogenes. However, there are two reasons
why we do not believe that nuclear pseudogenes are
contributing to our data. The first reason is, again, that
the mixtures in any one individual occur at only one or
(rarely) two positions. A nuclear pseudogene would seg-
regate in the population independently from maternally
transmitted mtDNA lineages. Different mtDNA line-
ages differ, on average, at four sites, and there would
be no reason to expect independently segregating pseu-
dogenes to correlate, in sequence similarity, with the
mtDNA types of individuals in which they are detected.
The second reason is that there is a known nuclear pseu-
dogene that is widely present in the general population
(Zischler et al. 1995; Thomas et al. 1996). This pseu-
dogene is highly distinctive, differing from the Cam-
bridge reference sequence at 27 positions in the 16164–
16365 region alone. Although our DGGE assay is ca-
pable of resolving this pseudogene from mitochondrial
sequences, we detected the pseudogene in only two in-
dividuals in our population survey. In both instances,
there was an F16144GC primer mismatch caused by a
polymorphism in the individual’s authentic mtDNA
sequence (not shown), resulting in reduced efficiency
of amplification of the mitochondrial component and
preferential coamplification of the pseudogene. In the
absence of an amplification primer mismatch, this com-
mon pseudogene was not detected in any of our samples.
This indicates that, under normal circumstances, the
abundance of mtDNA copies in a cell overshadows any
existing nuclear pseudogenes that may coamplify,
causing the nuclear sequences to go undetected by our
DGGE assay.
We conclude that the mixtures revealed by DGGE
represent variation in the endogenous mtDNA of the
individuals (or mtDNA lineages) studied. This is con-
sistent with the fact that the sites at which heteroplasmy
was observed have a higher-than-average rate of evo-
lutionary substitution. This would be expected if
mtDNA mutation were giving rise to the observed het-
eroplasmy, since site-by-site mutation rates in HV1 are
highly heterogeneous (Hasegawa et al. 1993; Wakeley
1993; Excoffier and Yang 1999; Meyer et al. 1999)
(table 2). Given the relative rates reported by Meyer et
al. (1999), the average relative rate of evolution for sites
where heteroplasmy was detected is 3.1 times greater
than the average relative rate over the entire HV1. If
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position 16093 is omitted, the average relative rates of
the heteroplasmic sites remain essentially the same (the
reported relative rate for position 16093 is itself 3.0
times the average). Very similar numbers are obtained
with the relative rates reported by Excoffier and Yang
(1999). We note that position 16104 has the lowest
estimated rate of evolution among the heteroplasmic
sites (roughly half the overall average rate), yet it none-
theless showed two instances of heteroplasmy. It is in-
teresting that both individuals had T—which occurs
rarely in the overall population—as the predominant
nucleotide. The significance of this, if any, is unclear.
The most striking observation in our study was the
high frequency and directionality of heteroplasmy at
position 16093. A total of 13 instances of heteroplasmy
were detected at 16093, and all but 2 had T—the ma-
jority population type—as the clear minority compo-
nent (one individual had C as the minority component,
and one had essentially equal proportions of C and T).
In population sequence databases, ∼6% of the popu-
lation carries a C, rather than a T, at 16093. In our
study set, 5% were heteroplasmic at 16093, and all but
two of these individuals would have been typed as “C”
in a standard sequencing study. This suggests that a
mechanistic bias determines variation at 16093. It seems
that C can readily be manifested as the majority base
within an individual’s mtDNA pool but that complete
fixation for C is rare. It is possible that developmental
selection acts against mtDNA pools that are fixed for
C at 16093. Alternatively, the base C at 16093 may be
hypermutable, so that a subpopulation of mtDNAs car-
rying 16093T are continually generated within individ-
uals originally fixed for 16093C. Similar hypermuta-
bility in the reverse direction (TrC) is not supported
by our data. Unusual mutational activity at position
16093 is supported by previous observations of inter-
generational “substitution” (a large shift in predomi-
nant type) (Parsons et al. 1997) and frequent hetero-
plasmy at 16093 (Sullivan et al. 1996; Armed Forces
DNA Identification Laboratory, unpublished data).
In this study, all samples were from blood. Thus, we
do not know whether the heteroplasmies we detected
were due to somatic mutations within an individual or
were inherited through the germline. It is possible that
both processes contributed. However, there is other ev-
idence that suggests that heteroplasmy within the CR
is not rarely an inherited condition. Parsons et al. (1997)
reported three instances of intergenerational substitu-
tion in HV1, including 16093, and the results of sub-
sequent DGGE studies indicated that these actually in-
volved heteroplasmic shifts of extreme ratio (not
shown). In addition, a comprehensive analysis of HV1
heteroplasmy among multiple postmortem tissues from
22 fetuses and 21 adults indicated a common occurrence
of low-level heteroplasmy shared among many tissues,
pointing toward the conclusion that the heteroplasmy
was inherited or, at least, originated very early in de-
velopment (Tully 1998). We do not have precise data
on the ages of many of the individuals in our current
population study, although we believe that none were
of the advanced ages represented in recently published
reports, which found aging-related accumulation of spe-
cific heteroplasmic mutations in the HV2 region of the
CR (Michikawa et al. 1999; Calloway et al. 2000). Also,
no longitudinal data were collected in our study. It re-
mains possible that the high-frequency heteroplasmies
(e.g., 16093) found in the present study could represent
aging-associated accumulation of heteroplasmy. How-
ever, in our previous study of postmortem fetal and
adult tissues, C/T heteroplasmy at position 16093 was
observed in individuals aged 29–52 years and in an 18-
wk-old fetus (Tully 1998).
It has repeatedly been hypothesized that the trans-
mission of a woman’s mtDNA population to her off-
spring is associated with a genetic bottleneck (Howell
et al. 1992; Poulton and Marchington 1996; Marching-
ton et al. 1997; Poulton et al. 1998). Offspring of a
heteroplasmic mother can display marked differences in
their heteroplasmic ratios, sometimes to the point of
apparent homoplasmic base substitutions (Parsons et al.
1997; Sekiguchi et al. 1999). In an investigation of the
segregation of point-mutation heteroplasmy in humans,
Bendall et al. (1996) traced heteroplasmy in HV1
through multiple mother-to-child transmissions in a
number of lineages and were able to derive estimates of
the most-probable effective bottleneck sizes from vari-
ous transmissions (range 1–46).
Bendall et al. (1996) also used the population fre-
quency of observed HV1 heteroplasmy and bottleneck
size estimates to calculate the “mutation rate” of the
HV1 region (in this instance, “mutation rate” refers to
the rate at which homoplasmic substitutions appear in
the population, as considered in most evolutionary phy-
logenetic studies). In that study, the incidence of het-
eroplasmy was estimated, by inspection of direct se-
quence data, to be 7 (1.48%) of 473 (that this value is
much lower than that which we report here is to be
expected, given that a general sequence survey was used
to estimate heteroplasmy rates). On the basis of this
number and a range of bottleneck size estimates and
thresholds for heteroplasmy detection, a mutation rate
of to site/generation was ob-6 51.2 # 10 2.7 # 10
tained. It was concluded that these values were in good
accord with previous phylogenetic estimates of the HV1
evolutionary rate.
We can apply the same calculation to our data, by
selecting a heteroplasmy-detection threshold of 5% (see
table 5 in Bendall et al. 1996) and by counting only
those observations that were measured at levels 5%.
This results in a calculated mutation rate of 1.8 #
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to site/generation (this range includes5 410 1.3 # 10
sampling error as well as a range of bottleneck sizes
from table 5 in a study by Bendall et al. [1996]). If we
omit position 16093, in recognition of the fact that
something unusual is occurring there with regard to
heteroplasmy and fixation, the range becomes 1.0 #
to site/generation. The latter estimate5 510 8.1 # 10
is higher than typical phylogenetic rate estimates and is
very close to the range of to site/5 52.4 # 10 8.0 # 10
generation that Parsons et al. (1997) reported as an
empirically estimated substitution rate for HV1 and
HV2. However, to these considerations, we would add
the caveat that the calculation of Bendall et al. (1996)
uses a probability of .5 that observed heteroplasmies
will become fixed for the mutant variant. In cases of
low-level heteroplasmy, we believe that the minority
component is more likely to be the new mutation and
that the chance that the newmutation will become fixed
would therefore be less than half. If we go to the extreme
case of adopting the premise that the new mutation is
the minority variant in every instance, and if we perform
the calculations assuming the probability of fixation is
equal to the minority proportion of the mixture, then
the range is to site/generation.6 52.6 # 10 2.1 # 10
This returns us to a range that is more similar to fre-
quently reported rates (Parsons et al. 1997; Jazin et al.
1998; Parsons and Holland 1998; Sigurdardottir et al.
2000); however, it is based on a premise that would
tend to underestimate the rate, and it does not take into
account the contribution of the heteroplasmic sites with
a measured proportion !.05. (We note that this cutoff
of .05 is made for purposes of direct comparison with
the analysis of Bendall et al. [1996] and that the ac-
curacy of our ratio quantitation [fig. 2] is such that the
cutoff should be considered to be an approximation).
Further resolution of the rate and manner of CR evo-
lution will likely result from a synthesis of additional
information on mutational variation within an individ-
ual (such as that provided by the present study), ad-
ditional information on the variation in the germline
between immediate generations, and the patterns of
change inferred at the larger population level, as shown
in Meyer et al. (1999) and Excoffier and Yang (1999).
The widespread and rather frequent occurrence of
heteroplasmy throughout HV1 has implications for fo-
rensic testing that is based on comparisons of mtDNA
sequences. The effect of heteroplasmy is well illustrated
by the case of Tsar Nicholas II. The mtDNA from skel-
etal remains believed to be those of the Tsar was shown
to be heteroplasmic in HV1, but no heteroplasmy was
evident in known living maternal relatives of the Tsar
(Gill et al. 1994). This perceived “mismatch” caused
some confusion until heteroplasmy was also confirmed
in the skeletal remains of the Tsar’s brother (Ivanov et
al. 1996). In that case, co-occurrence of heteroplasmy
provided an additional level of variation, thereby
greatly strengthening the identification. The results of
the present systematic survey of HV1 heteroplasmy are
consistent with general experience in the practical arena
of forensic testing, where heteroplasmy is now encoun-
tered with regularity. The effect of heteroplasmy is of
particular importance in cases where an unknown sam-
ple and a comparative reference sample are separated
by the action of a genetic bottleneck between genera-
tions or between single hairs (Sullivan et al. 1996; Ben-
dall et al. 1997; Holland and Parsons 1999; Grzybow-
ski 2000). Apparent single-base differences, or hetero-
plasmy in only one of two compared samples, can be
due to differential segregation of heteroplasmy from the
same biological source. Quantitative knowledge of the
rate and pattern of HV1 heteroplasmy provided in this
study can be used to guide interpretation in such cases.
For example, heteroplasmic differences at position
16093 can be considered to be of little significance be-
cause of the high frequency of heteroplasmy there,
whereas differences at several positions known to have
very low rates of heteroplasmy would provide much
stronger evidence that the samples are not from the same
biological source or lineage (forensic treatment in such
cases is reviewed by Holland and Parsons [1999]).
Our results indicate that heteroplasmy in HV1 of the
human mtDNA CR is more common in the general
human population than was previously believed. Until
recently, intraindividual variation in this important seg-
ment of DNA was unknown or was considered to be
of minimal significance (Stoneking 1996). The picture
that is now emerging is one in which the study of
mtDNA population genetics and evolution must view
the mtDNA pool both within an individual and among
individuals in a maternally related lineage as a dynamic
source of variation. The challenge now is to understand
how the complex “microevolutionary” processes of
mtDNA mutation, segregation, and transmission affect
the more-traditional population genetics patterns of
mtDNA variation that have long been studied. It may
be that a better understanding of these underlying pro-
cesses will provide new insight and will substantially
extend our ability to draw conclusions from mtDNA
population genetics and phylogenetic analyses.
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